[
    [
        {
            "time": "",
            "original_text": "[强于大市评级]部分医药个股纳入MSCI点评(医药生物行业)：医药部分个股纳入MSCI 看好长期价值",
            "features": {
                "keywords": [
                    "MSCI",
                    "医药",
                    "生物",
                    "个股",
                    "长期价值"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强于大市评级]部分医药个股纳入MSCI点评(医药生物行业)：医药部分个股纳入MSCI 看好长期价值",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[买入评级]凯莱英(002821)重大事项点评：加入MSCI指数体系 获国际资本市场认可",
            "features": {
                "keywords": [
                    "凯莱英",
                    "MSCI",
                    "指数体系",
                    "国际资本市场",
                    "认可"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]凯莱英(002821)重大事项点评：加入MSCI指数体系 获国际资本市场认可",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]